CymaBay Therapeutics
(NASDAQ:CBAY)
$2.77
-0.18[-6.10%]
At close: Jul 1
$2.77
00
After Hours: 4:30PM EDT
Day High/Low2.77 - 2.98
52 Week High/Low1.67 - 4.74
Open / Close2.94 / 2.77
Float / Outstanding71.6M / 84.7M
Vol / Avg.387.3K / 769.3K
Mkt Cap234.6M
P/E-
50d Avg. Price2.18
Div / Yield-
Payout Ratio-
EPS-0.32
Total Float71.6M

CymaBay Therapeutics (NASDAQ:CBAY), Quotes and News Summary

CymaBay Therapeutics (NASDAQ: CBAY)

Day High/Low2.77 - 2.98
52 Week High/Low1.67 - 4.74
Open / Close2.94 / 2.77
Float / Outstanding71.6M / 84.7M
Vol / Avg.387.3K / 769.3K
Mkt Cap234.6M
P/E-
50d Avg. Price2.18
Div / Yield-
Payout Ratio-
EPS-0.32
Total Float71.6M
Sector: Health Care.Industry: Pharmaceuticals
CymaBay Therapeutics Inc is a clinical-stage biopharmaceutical company. Its main business involves the development of therapeutics such as Arhalofenate, MBX-8025, and MBX-2982. These drugs are intended to treat serious metabolic disorders. Arhalofenate is used to treat gout, MBX-2982 is an oral, G-protein coupled receptor agonist being evaluated as a therapeutic agent for patients with Type 2 diabetes and MBX-8025 is a selective agonist for the peroxisome proliferator-activated receptor delta.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.310-0.320 -0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

CymaBay Therapeutics Questions & Answers

Q
How do I buy CymaBay Therapeutics (CBAY) stock?
A

You can purchase shares of CymaBay Therapeutics (NASDAQ: CBAY) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are CymaBay Therapeutics's (CBAY) competitors?
Q
What is the target price for CymaBay Therapeutics (CBAY) stock?
A

The latest price target for CymaBay Therapeutics (NASDAQ: CBAY) was reported by B. Riley Securities on Wednesday, May 18, 2022. The analyst firm set a price target for 8.00 expecting CBAY to rise to within 12 months (a possible 188.81% upside). 4 analyst firms have reported ratings in the last year.

Q
Current Stock Price for CymaBay Therapeutics (CBAY)?
A

The stock price for CymaBay Therapeutics (NASDAQ: CBAY) is $2.77 last updated July 1, 2022, 8:00 PM UTC.

Q
Does CymaBay Therapeutics (CBAY) pay a dividend?
A

There are no upcoming dividends for CymaBay Therapeutics.

Q
When is CymaBay Therapeutics (NASDAQ:CBAY) reporting earnings?
A

CymaBay Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is CymaBay Therapeutics (CBAY) going to split?
A

There is no upcoming split for CymaBay Therapeutics.

Q
What sector and industry does CymaBay Therapeutics (CBAY) operate in?
A

CymaBay Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.